The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease

This methodology research of AD RCTs highlights substantial changes in key features of AD clinical trials from 1992 to 2024. AD RCTs have become larger and longer, such that they are powered to detect smaller clinical differences. The increased sample sizes and duration should enable the detection of smaller and more slowly occurring outcomes, which may lead to successful RCTs of therapies with slower and more subtle efficacy.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-08-29
DOI
https://doi.org/10.1001/jamanetworkopen.2025.29665
Citations
1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease

Angela T.H. Kwan, Tharick Ali Pascoal, Joseph Therriault, Eduardo Rigon Zimmer et al.
1 citations
JAMA Network Open
Health Systems, Economic Evaluations, Quality of Life
3.13
article

The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease

Angela T.H. Kwan, Tharick Ali Pascoal, Joseph Therriault, Eduardo Rigon Zimmer, Saman Arfaie, Marcel S. Woo, Giovanna Carello‐Collar, Nesrine Rahmouni, Arthur C. Macedo, Stijn Servaes, Brandon J. Hall, Cécile Tissot, Étienne Aumont, Jean‐Paul Soucy, Pedro Rosa‐Neto, Paolo Vitali, Serge Gauthier, Lydia Trudel, João-Pedro Ferrari-Souza
article en
1 citations

Abstract

This methodology research of AD RCTs highlights substantial changes in key features of AD clinical trials from 1992 to 2024. AD RCTs have become larger and longer, such that they are powered to detect smaller clinical differences. The increased sample sizes and duration should enable the detection of smaller and more slowly occurring outcomes, which may lead to successful RCTs of therapies with slower and more subtle efficacy.

JAMA Network OpenVol. 8(8)
Universidade Federal do Rio Grande do Sul (BR), Lawrence Berkeley National Laboratory (US), University of Ottawa (CA), Universität Hamburg (DE), University of Pittsburgh (US), Southwestern Medical Center (US), University Medical Center Hamburg-Eppendorf (DE), McGill University (CA), The University of Texas Southwestern Medical Center (US), University of California, Berkeley (US)
Openalex Percentile: Top 7%
Health Systems, Economic Evaluations, Quality of Life
3.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.